EAN 2026: Education and Eptinezumab Help Reduce Medication Overuse in Chronic Migraine

A brief educational intervention combined with eptinezumab reduced migraine frequency and acute medication use in patients with chronic migraine and medication overuse, according to findings presented at EAN 2026. Rigmor Højland Jensen, Professor and Director of the Danish Headache Center, discusses why education, withdrawal of acute medication, and early preventive treatment are key to improving outcomes.